Wednesday, January 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

India Completes First Biodefense Level 4 Lab

by Global Biodefense Staff
March 11, 2013

BSL Level 4 Biodefense Lab (NIAID)Officials from the Indian Council of Medical Research last week announced completion of the nation’s first Bio-Safety Level 4 (BSL 4) high containment laboratory. 

The new biodefense lab is located on the main campus of the Microbial Containment Complex at the National Institute of Virology (NIV) in Pune. The complex had already been operating laboratories at a BSL 3+ Level for hazardous pathogens. 

“This facility is an expansion of current work going in NIV, Pune and would be tremendously useful in investigation outbreak of highly infectious diseases like Severe Acute Respiratory Syndrome (SARS), Avian and pandemic Swine Influenza, Nipah virus, Crimean Congo hemorrhagic fever virus and Kyasanur forest disease virus which created fear and affected at large our country,” states the Ministry of Health and Welfare. “It will also deal with other highly infectious pathogens emerging in the country in future.”

As most of the viral agents listed as tools of bioterrorism are of BSL-4 category, officials state the new laboratory will give the nation increased capability to deal with agents of bioterrorism.

“We wanted to make reagents and our requests to BSL-4 laboratories outside the country were not entertained,” stated N.K. Ganguly, former director of the Indian Council of Medical Research and reported early champion of the project. “That’s when we decided to set up our own facility and partnered with the Department of Science and Technology for the effort.”

The National Institute of Virology is a World Health Organization (WHO) Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, National Influenza Center in India, and Influenza A H5 Reference Laboratory for South East Asia.

The total expenditure for project is reported as Rs. 65 crores (approximately $11.9 million USD).

Tags: Avian InfluenzaBiosafetyBioterrorismNipah Virus

Related Posts

DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
New Framework for Livestock Disease Indemnity Valuation Proposed by USDA
Biosecurity

New Framework for Livestock Disease Indemnity Valuation Proposed by USDA

September 10, 2022
Waterfowl on a seashore
Biosecurity

HPAI Concerns Prompt U.S. Restrictions on Hunter Harvested Wild Bird Game Meat from Canada

September 2, 2022
Tagged livestock in a row
Biosecurity

Consider Farmers at Individual Level When Controlling Livestock Disease Outbreaks

July 15, 2022
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy